PROVIDER PROFILE · NPI 1912191347

Guido MacchiavelloM.D.

HospitalistNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$2K

Peer benchmark

Total Medicare services vs. 1,636 Hospitalist providers in NY — bottom quintile (cohort median 462).

PRESCRIBING · PART D · 2024

Total Rx claims

4,393

Beneficiaries

—

Total drug cost

$605K

Distinct drugs

Brand share

33.0%

Top prescribed drugs

Atorvastatin Calcium351 claims

Albuterol Sulfate254 claims

Lisinopril218 claims

Rosuvastatin Calcium217 claims

Amlodipine Besylate182 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$871

Payment records

By payment type

Food and Beverage$871

REFERRAL NETWORK

Where Guido Macchiavello's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
David Green Diagnostic Radiology · Summit, NJ	29	122
John Della Badia Diagnostic Radiology · Bronx, NY	18	51
Alida Rosado Rodriguez Internal Medicine · Andover, MA	14	49
Jeffrey Gunzenhauser Diagnostic Radiology · Brooklyn, NY	14	50
TC AMBULANCE CORPORATION	14	29
Abdurhman Ahmed Nephrology · Bronx, NY	13	76
New York City Health And Hospitals Corporation Ambulance Service Provider · Brooklyn, NY	12	38

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history